MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4960 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-04-07 (aktien-mag.de)
Beta Bionics revolutionizes the insulin pump market with the only adaptive closed loop algorithm!
The medical technology company Beta Bionics (BBNX) only completed its IPO on January 29 and wants to revolutionize the treatment of type 1 diabetes with the ILET insulin pump system. As a fully automated bionic pancreas (pancreas) in the United States, this is intended to address a $ 2 billion pump market and 1.8 million affected patients. ILET is considered the first and only adaptive closed loop algorithm for automated insulin management approved by the FDA. With the input of body weight alone, the algorithms can automate insulin dosage. Previous hybrid-closed loop solutions by competitors Insulet, Medtronic and Tandem Diabetes Care are much more complex by specifying carbohydrates for meals, manually calculated correction doses or adapting the insulin basal rate.
Read more
2025-04-01 (capedge.com)
Picard Medical S1 IPO registration | PMI 1 Apr 25
IPO registration, S-1 SEC filing by Picard Medical on 1 Apr 25, 6:45am
Read more
2024-11-22 (nasdaq.com)
Medline Industries Could Launch a $5B IPO in 2025 |
New reports claim that medical supply company Medline Industries is planning for an initial public offering (IPO) as early as Q2 2025. This could see the privately held company raise roughly $5 billion, which would result in a market value of about $50 billion.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now At 40% OFF!Make smarter investments with weekly expert stock picks from the Smart Investor NewsletterInvestors will note that Medline Industries is owned by private-equity firms Blackstone (BX), Carlyle (CG), and Hellman & Friedman. These firms came together in 2021 to purchase Medline Industries in a $34 billion deal.It also bears mentioning that this isn't the first time Medline Industries has gone public. The company made its public debut in 1972 but went private again just five years later.Can Medline Industries Challenge Medtronic?First off, traders will keep in mind that Medline Industries is not a lightweight in the medical supply industry.
Read more
2024-08-01 (hankyung.com)
Next Biomedical holds IPO corporate briefing session
Next Biomedical holds an IPO corporate briefing session and will leap forward as a global convergence medical solution company” ▶ Targeting the global market with the goal of listing innovative treatments as global standard treatments ▶ Demand forecast for 5 days from July 29 to August 2 In progress, subscription scheduled for August 7-8
Read more
2024-06-04 (auntminnieeurope.com)
Medtronic completes €30B public offering
Medtronic has completed a $33 billion (€30.3 billion) public offering of senior notes.
Read more
2024-05-10 (massdevice.com)
Retriever Medical launches Series A funding round to advance thrombectomy system
Retriever Medical is on the hunt for investors to fund continued development and FDA 510(k) clearance of its unique thrombectomy system.
Read more
2023-08-24 (massdevice.com)
Sanuwave to go public in $127.5M SPAC merger
Wound care company Sanuwave Health announced that it entered into a business combination agreement with SEP Acquisition Corp.
Read more
2023-07-25 (massdevice.com)
NeuroOne prices $5.25M public offering
NeuroOne Medical Technologies (Nasdaq:NMTC) announced today that it priced an underwritten registered public offering.
Read more
2023-05-31 (fool.com)
Is It Too Late to Buy Medtronic's Stock?
This healthcare stock could help your money grow while also providing you with passive income.
Read more
2023-04-20 (legaldesire.com)
DLA Piper advises Medtronic on public offering of USD2 billion
DLA Piper has advised Medtronic Global Holdings S.C.A. ( Medtronic LuxCo) on its registered public offering( Offering) of a total of USD2 billion notes, consisting in an aggregate principal amount of USD1 billion of 4.250% senior notes due 2028 and USD1 billion aggregate principal amount of 4.5000%
Read more
2023-02-17 (irishtimes.com)
Weight loss device maker Allurion Technologies closes on deal to go public
Merger mooted with blank-check firm backed by ex-Medtronic chief Omar Ishrak, according to sources
Read more
2022-07-05 (massdevice.com)
Orchestra BioMed to go public, partner with Medtronic on cardiac neuromodulation therapy
Orchestra BioMed today announced a slew of agreements, including a strategic collaboration with Medtronic.
Read more